Skip to main content

Table 2 Comparison of the hormonal characteristics among the conceived and nonconceived subjects

From: Androstenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study)

 

Group I (Control Group)

Group II (PCOS Group)

 

Did not conceive

Conceived

Did not conceive

Conceived

Primary A4 a

0,88 ± 0.45

0,96 ± 0.2

1,39 ± 0.08

1.4 ± 0.33

A4 (AUC)b

3,06 ± 2.8

2.8 ± 1.3

4,2 ± 0.7

10.7 ± 7.1

E2(AUC)c

1916,6 ± 206.3

2942.7 ± 1058.4

2654,2 ± 677.3

4212.7 ± 767.2

AMHd

2,53 ± 1.2

3.0 ± 0.41

9.23 ± 1

8.6 ± 1.5

HOMA-IRe

3,08 ± 0.3

2.4 ± 0.6

3,2 ± 0.34

2.22 ± 0.33

Time Lag A 4 -E 2 Response

−0,92 ± 0.46

−0,67 ± 0.4

−0,23 ± 0.11af

−3.79 ± 0.86af

  1. aThe initial blood androstenedione level (ng/mL)
  2. bArea under the curve value for Androstenedione (ng*days)
  3. cArea under the curve value for estradiol (pg*days)
  4. dAntimüllerian hormone (ng/mL)
  5. eHomeostasis Model for Assessment of Insulin Resistance
  6. f P<0.05
Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us